| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |